Thank you for subscribing.

Please check your email to confirm.

Unsubscribe success..

You already subscribed and confirmed.

Please check your email.

You already subscribed.

Please check your email to confirm.

Linking Med Gets Class III, Paving the way for Monetization for Hi-tech Medical Startups
Linking Med Gets Class III, Paving the way for Monetization for Hi-tech Medical Startups
"Change is the law of life. And those who look only to the past or present are certain to miss the future." John F. Kennedy Image: Credit to Sebastian Pichler on Unsplash
Associated Company
深睿医疗 深睿医疗

In August this year the National Medical Products Administration (NMPA) issued a Class III type license to Linking Med (连心医疗), a Beijing-based medical-cloud company that focuses on the processing of oncological medical images. The licensing will facilitate the company’s commercialization of its cloud solution.

The first-of-its-kind license is of enormous importance, since it brings the possibility for the other AI-and cloud-driven medical companies to monetize their products.  

The company’s cloud solution, which was licensed by the NMPA, has already landed in more than 50 hospitals, serving over 2,000 people per week; since the license was obtained, the cloud-provider has been negotiating the price with hundreds of hospitals, according to VCbeat, a Chinese media organization.

NMPA, the regulatory department responsible for the permission and licensing of Class III-type products, took over the duty from the China Food and Drug Administration (CFDA) in 2018, after a major regulatory update by China’s State Council in 2018 that merged the CFDA and several other departments into the NMPA. From 2018 onwards, NMPA has been the official entity that directly reports to the State Council.

The medical cloud provider has been generating its revenue from third-party services to the hospital’s radiotherapy departments in China. Since the country has structural problems in cancer treatment that are due to excess demand on very scarce resources, medical cloud and remote consultation have been showing potential as one of the best integrated solutions to the problem, which is Linking Med’s focus. (Check out this in-depth article on China’s structural problems in healthcare).

Linear Capital (线性资本) backed health-tech company’s licensing success is good news for the rest of the industry, especially for those who have a medical cloud system that is supported by machine learning and AI. Founded in early 2016, VoxelCloud (体素科技) is one of those companies who provide intelligent cloud systems. Yet another example is 12Sigma (图玛深维), a Jiangsu-based Medical AI developer known for its lung and breast cancer-related MI diagnosis product.

Several industry experts have argued that ‘Chinese regulators will not provide a Class III-type of license to any AI-driven medical product in the short-term,’ yet this licensing event shows that the regulators in China are not as ‘conservative’ as some expected. Indeed, it may be just be a beginning for the entire IT and big data-driven healthcare services scene in China.

“2019 may be a heaven for monetization in China’s medical AI scene,” once said the CEO of deepwise to EqualOcean. Perhaps he is right in his optimism. 

Enterprises Information

深睿医疗是一家人工智能医疗应用开发商,并与多家国内顶级的医疗机构保持长期科研合作。
CATEGORIES: AI, Healthcare, Medical Imaging, Medical Institution, Smart Medical, Medical Instrument, Medical Device, Medical Informatization
Last Funding Type
Series A+
Number of Employees
51-100
Number of Funding Rounds
4
VoxelCloud 用人工智能和云计算技术深度挖掘海量医疗影像和临床数据,助力医生对疾病进行精准、
CATEGORIES: AI, Smart Device, Healthcare, AI Medical, Medical Institution, Medical Insurance, Smart Medical, Smart Finance, Medical Informatization, Data Analysis
Last Funding Type
Series B
Number of Employees
51-100
Number of Funding Rounds
4
图玛深维医疗致力于研发基于深度学习技术的自动化医疗诊断与医学数据分析系统
CATEGORIES: AI, Deep Learning, Healthcare, Medical Imaging, Smart Medical, Medical Informatization
Last Funding Type
Series B
Number of Employees
101-300
Number of Funding Rounds
4

Enterprises Information

深睿医疗
深睿医疗是一家人工智能医疗应用开发商,并与多家国内顶级的医疗机构保持长期科研合作。
CATEGORIES: AI, Healthcare, Medical Imaging, Medical Institution, Smart Medical, Medical Instrument, Medical Device, Medical Informatization
Last Funding Type
Series A+
Number of Employees
51-100
Number of Funding Rounds
4
体素科技
VoxelCloud 用人工智能和云计算技术深度挖掘海量医疗影像和临床数据,助力医生对疾病进行精准、
CATEGORIES: AI, Smart Device, Healthcare, AI Medical, Medical Institution, Medical Insurance, Smart Medical, Smart Finance, Medical Informatization, Data Analysis
Last Funding Type
Series B
Number of Employees
51-100
Number of Funding Rounds
4
图玛深维
图玛深维医疗致力于研发基于深度学习技术的自动化医疗诊断与医学数据分析系统
CATEGORIES: AI, Deep Learning, Healthcare, Medical Imaging, Smart Medical, Medical Informatization
Last Funding Type
Series B
Number of Employees
101-300
Number of Funding Rounds
4

Reach the Author!

Ask the author questions about the copied text

MOST READ

THE LATEST

Speaking Up: AISpeech Nets USD 58 Million in Series E
The voice recognition startup broke even in 2018.

Speaking Up: AISpeech Nets USD 58 Million in Series E

Any Question

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers